Objective: To determine whether inotropic responses to the b-adrenergic agonist dobutamine are potentiated by systemic inhibition of v nitric oxide synthase (NOS) with the L-arginine analogue N -nitro-L-arginine (L-NNA), and to establish to what extent any observed responses are related to the increase in aortic blood pressure accompanying systemic NOS inhibition. Methods: Dobutamine was infused incrementally at rates of 1, 2.5, 5 and 10 mg / kg / min in 15 open-chest, anaesthetised ewes before and after inhibition of NO synthesis with i.v. L-NNA (n58), or elevation of mean aortic blood pressure to the same extent as attained with NOS inhibition using proximal arterial occlusion (n57). Results: By the peak infusion rate, dobutamine increased the maximal rate of rise of left ventricular pressure (LV dP/dt ) by 100% ( p,0.001) and reduced LV stroke work by 18% ( p,0.01). L-NNA and arterial occlusion increased resting mean MAX aortic blood pressure by 5564 and 5163 mmHg respectively. Compared to dobutamine alone, subsequent peak dobutamine-related increases in LV dP/dt were augmented by 76% after L-NNA and by 88% after arterial occlusion (both p,0.001). Moreover, MAX dobutamine increased LV stroke work by 23% at infusion rates of 1-5 mg / kg / min ( p,0.001) after L-NNA, and by 17% at an infusion rate of 1 mg / kg / min ( p,0.01) after arterial occlusion. Conclusions: Systemic NOS inhibition potentiates the effects of dobutamine on LV isovolumic and pumping performance in the intact circulation, but this potentiation is in large part related to the increase in arterial blood pressure accompanying NOS inhibition.
Introduction
versely, inhibition of NOS with N -nitro-L-arginine (L-NNA), a stereospecific analogue of L-arginine, enhanced b-adrenergic agonists, via stimulation of adenylate the positive inotropic action of isoproterenol in isolated rat cyclase and enhanced myocardial production of cyclic ventricular myocytes [7] . Moreover, infusion of a NOS AMP, constitute a powerful mechanism for augmenting the inhibitor into the left main coronary artery augmented performance of the heart [1]. Recent in vitro and in vivo increases in the maximal rate of rise of left ventricular findings suggest, however, that b-adrenergic inotropic (LV) pressure during subsequent intracoronary administraactions in the heart may normally be limited by nitric tion of dobutamine in humans [8] and anaesthetised dogs oxide (NO), a ubiquitous compound which is synthesised [9] . from the amino acid L-arginine by the constitutive isoform It is unknown, however, if changes in LV function of the enzyme NO synthase (NOS) [2] [3] [4] . Thus, provision induced by intravenous infusion of b-adrenergic agents are of exogenous NO decreased contractile responses to influenced by systemic inhibition of NO synthesis, a noradrenaline in isolated papillary muscles [5] and to question with potentially important clinical implications isoproterenol in isolated myocytes and hearts [6] . Conbecause the combined use of b-adrenergic agonists and NOS inhibitors has been advocated in the setting of conditions such as endotoxaemia [10] , which are characterIthaca, NY, USA) was placed around the ascending aorta. ised by poor responsiveness to inotropic agents [11] . In A Teflon cannula was inserted through an adventitial addition, it is unknown to what extent any changes in purse-string suture into the proximal descending aorta and b-adrenergic inotropic responses are related to the vascular connected to a polyvinyl extension tubing for blood effects of NOS inhibition, an issue of particular relevance sampling and pressure measurement. A catheter was because systemic administration of a NOS inhibitor raises passed into the left atrial cavity via the appendage for aortic blood pressure [2, 12, 13] and it has been previously pressure measurement, while a 5F micromanometer-tipped demonstrated that inotropic responses to isoproterenol can catheter (MPC-500, Millar Instruments, Houston, TX, be augmented by superimposed increases in aortic blood USA) was inserted through the roof of the left atrium and pressure [14, 15] .
passed transmitrally into the LV cavity to measure LV Accordingly, this study had two aims. The first was to pressure. The edges of the pericardial incision were then examine the effect of systemic NOS inhibition produced loosely re-approximated using a continuous suture. by intravenous infusion of the L-arginine analogue L-NNA on LV inotropic responses during an incremental intraven-2.2. Experimental protocol ous infusion of the b-adrenergic agonist dobutamine in the intact circulation. The second was to compare these After the completion of surgery, haemodynamics were responses with those produced by a non-pharmacological monitored for at least 15 min to ensure stability of the elevation of arterial pressure to a similar mean level as experimental preparation. Subsequently, baseline haemoattained with NOS inhibition via the use of partial arterial dynamic variables were recorded before dobutamine occlusion.
(David Bull, Victoria, Australia), a synthetic sympathomimetic with potent b -adrenoceptor-mediated inotropic 1 actions as well as minor b and a -adrenoceptor effects 2 1 2. Methods [16] , was infused continuously into the superior vena cava in incremental steps of 1, 2.5, 5 and 10 mg / kg / min using ä All experiments were performed in accordance with the roller pump (model MS 4-Reglo, Ismatec, Zurich, Switzerguidelines of the National Health and Medical Research land). After steady-state conditions had been attained 5-10 Council of Australia and were approved by the Monash min into each dobutamine dose, haemodynamic measureUniversity Animal Experimentation Ethics Committee.
ments were repeated and the dobutamine infusion was increased to the next dose. Following completion of 2.1. Acute surgical preparation measurements at the highest dose, the dobutamine infusion was progressively reduced over a period of 15 min and Fifteen Border-Leicester cross sheep, weighing then stopped. A 30 min recovery period, which corres-49.561.4 kg (mean6SEM) were anaesthetised with an ponded to more than ten dobutamine circulating half times intramuscular injection of ketamine (5 mg / kg) and [17] , was then allowed to ensure adequate clearance of this xylazine (0.1 mg / kg), and an intravenous bolus of acompound from the circulation. chloralose (25-50 mg / kg). Anaesthesia was maintained Following the initial dobutamine infusion, animals were with a continuous intravenous infusion of a-chloralose at a allocated into one of two groups. In eight animals, NO rate of 12-25 mg / kg / h. Animals were intubated with a synthesis was inhibited with the stereospecific NOS inhibcuffed endotracheal tube and ventilated with oxygen-enitor, L-NNA (Sigma, St. Louis, MO, USA), administered riched air using a large animal respirator (model 607, intravenously over 15 min at a dose of 25 mg / kg. Harvard Apparatus, Dover, MA, USA). Ventilation was Preliminary studies indicated that no further increases in adjusted to maintain arterial O tension between 100 and mean systemic arterial blood pressure occurred above this 2 120 mmHg, and arterial CO tension between 35 and 40 dose of L-NNA in our experimental preparation. In the 2 mmHg. Blood acid-base status was monitored with freremaining seven animals, mean arterial pressure was quent arterial blood gas determinations and base deficits increased to a similar level as obtained with L-NNA by were corrected with sodium bicarbonate as required. Body combining partial inflation of a 5F Fogarty atrial septostemperature was maintained between 38.5 and 408C with a tomy catheter (Baxter Healthcare, IL, USA) which was combination of a heating pad and towel covering.
passed into the brachiocephalic trunk via the left axillary The neck was incised in the midline and polyvinyl artery, with subtotal occlusion of the descending thoracic catheters were advanced through the left external jugular aorta produced by tightening of a mechanical snare. vein into the superior vena cava for fluid and drug Mechanical occlusion of distal segments of the central infusion. After a left thoracotomy was performed in the arteries was specifically chosen to increase aortic pressure fourth intercostal space, the fourth and fifth ribs were because it generates a large arterial reflected wave in the sectioned anteriorly and posteriorly to increase exposure of latter part of systole that imposes a load on the left the heart and great vessels. A 20 mm diameter perivascular ventricle akin to that produced by an increase in peripheral ultrasonic flow probe (model 20SS, Transonic Systems, resistance [18, 19] , i.e., the haemodynamic change which accompanies systemic inhibition of NO synthesis were partitioned into individual degrees of freedom, while [2, 12, 13] .
differences between the initial and post-L-NNA or postFollowing administration of L-NNA or the institution of arterial occlusion dobutamine infusions were assessed with partial arterial occlusion, haemodynamics were allowed to paired t-tests, using the Bonferroni procedure as required stabilise for 10-15 min. Haemodynamic measurements for multiple tests [22] . Differences in haemodynamic were then repeated in each group of animals, before and responses between L-NNA and aortic occlusion groups during a second incremental infusion of dobutamine at were evaluated with unpaired t-tests. Results are expressed dose rates of 1, 2.5, 5 and 10 mg / kg / min. At the end of as mean6SEM and the null hypothesis was rejected at the experiment, the animal was killed with an overdose of p,0.05. pentobarbitone sodium.
Physiological variables

Results
Aortic and left atrial pressures were measured with 3.1. Effect of dobutamine infusion silicon chip pressure transducers (CDX-111, COBE Laboratories, Lakewood, CO, USA), which were calibrated
Responses to infusion of dobutamine alone were similar against a water manometer before each experiment. Vascuin the L-NNA and aortic occlusion groups, and the data lar pressures were referenced to atmospheric pressure at have therefore been combined. Stepwise infusion of the level of the midthoracic vertebral spines. Ascending dobutamine to a peak dose of 10 mg / kg / min was associaortic blood flow was measured with an ultrasonic flowated with progressive increases in heart rate, ascending meter (model T208, Transonic Systems). The maximal rate aortic flow and LV dP/dt (all p,0.001). Mean aortic MAX of rise of LV pressure (dP/dt ), which was used to pressure increased by 462 mmHg between baseline and 1 MAX assess LV isovolumic function, was obtained using an mg / kg / min dobutamine ( p,0.01), but then fell to a level on-line differentiator (model 100, Baker Institute, Victoria, 763 mmHg lower than baseline at the highest dobutamine Australia) having an output that was directly proportional infusion rate ( p,0.005). LV stroke volume decreased by to frequency (65%) up to 90 Hz. The outputs from the 10.161.5 ml between baseline and 5 mg / kg / min pressure and flow transducers were amplified using an dobutamine ( p,0.001) and was unchanged at the higher eight-channel programmable signal conditioner (Cyberamp dose, whereas LV stroke work fell between baseline and 380, Axon Instruments, Foster City, CA, USA) and 2.5 mg / kg / min dobutamine ( p,0.01), and then plateaued displayed continuously on a direct-writing recorder (Neotat higher infusion rates (Table 1) . race 800Z, Neomedix Systems, New South Wales, Australia). Following passage through a 24 Hz low-pass filter 3.2. Effect of L-NNA or partial arterial occlusion to prevent aliasing, pressure and flow signals were digitised at a sampling rate of 500 Hz for 20 s, and the data Administration of L-NNA increased mean aortic presstored on computer for subsequent off-line analysis using sure by 5564 mmHg ( p,0.001) and was accompanied by customised interactive software. rises in mean left atrial pressure ( p,0.001) and LV stroke LV stroke volume was calculated as ascending aortic work ( p,0.001), decreases in heart rate ( p,0.025) and blood flow divided by the heart rate. The total LV work ascending aortic flow ( p,0.01), but no significant change performed during each cardiac cycle (i.e. the LV stroke in LV stroke volume or dP/dt ( Table 2 v Haemodynamic variable and LV performance before (pre-L-NNA) and after inhibition of NO synthesis with N -nitro-L-arginine (post-L-NNA), as well as before (pre-occlusion) and after partial occlusion of the descending aorta and brachiocephalic trunk (post-occlusion). increases in heart rate were attenuated by 41% after L-NNA ( p,0.05) and by 26% after partial arterial occlusion ( p,0.05; Fig. 2A ), but ascending aortic flow responses were not significantly affected by either intervention (Fig.  2B) . After L-NNA, LV stroke volume did not change significantly at infusion rates #5 mg / kg / min, but fell to a value 6.062.9 ml lower than baseline at the highest dose ( p,0.05). On the other hand, after arterial occlusion, LV stroke volume was unchanged at 1 mg / kg / min and then paralleled the initial decline, albeit at a higher value ( p,0.01; Fig. 2C commencement of dobutamine, and was not significantly different from the initial infusion at dobutamine doses $2.5 mg / kg / min (Fig. 2E) 
LV isovolumic function
Both L-NNA and partial arterial occlusion enhanced dobutamine-related increases in LV dP/dt ( p,0.001)
MAX
to a similar degree. This enhanced effect was most pronounced at dobutamine infusion rates of $2.5 mg / kg / min and, at the highest dobutamine dose, amounted to an increment of 13906155 mmHg / s ( p,0.001) and 15206230 mmHg / s ( p,0.001) for the L-NNA and arterial occlusion groups respectively (Fig. 3A) .
LV stroke work
In contrast to the initial reduction, dobutamine after L-NNA increased LV stroke work between infusion rates of 
025).
After partial arterial occlusion, LV stroke work exceeded the baseline value at the initial dobutamine dose (incre-22 ment 9.464.1 J?10 ; p,0.01), and then declined progressively to a level not statistically different from baseline at the 10 mg / kg / min infusion rate (Fig. 3B) .
Discussion
Two main findings have emerged from this study, which sought to determine whether LV inotropic responses to the b-adrenergic agonist dobutamine were potentiated by sponses were related to the increase in aortic blood pressure accompanying NOS inhibition. First, NOS inhibisimilar with respect to blunting of heart rate responses, tion not only augmented increases in LV isovolumic falls in mean left atrial pressure and a dampening of function occurring with dobutamine infusion but, in conreductions in LV stroke volume, aortic blood pressure trast to the reduction observed with dobutamine alone, also responses differed substantially. Thus, whereas increased LV stroke work at low and intermediate infusion dobutamine-induced blood pressure changes before and rates. Second, following elevation of aortic pressure via after arterial occlusion paralleled one another, both the partial arterial occlusion to a level equivalent to that initial rise and subsequent fall in arterial blood pressure produced by NOS inhibition, dobutamine infusion resulted were accentuated during dobutamine infusion after NOS in a similar augmentation of LV isovolumic function and, inhibition. The former is consistent with results which at the initial infusion rate, a rise in LV stroke work. These indicate that a -adrenoceptor-mediated vasoconstrictor 1 observations suggest that systemic inhibition of NO syneffects are enhanced by NOS inhibition [30, 31] . By thesis potentiates the LV inotropic actions of b-adrenergic contrast, the greater reduction in aortic blood pressure stimulation in the intact circulation, but that this potentiaoccurring at dobutamine infusion rates $5 mg/kg/min was tion is in large part related to the rise in aortic blood somewhat surprising, given that NO appears to play a pressure accompanying NOS inhibition.
contributory role in b-adrenoceptor-mediated vasodilation In accord with its potent b -adrenoceptor activity [16] , [32, 33] . However, a plausible explanation for this greater 1 infusion of dobutamine alone substantially increased heart reduction was that, akin to the pulmonary circulation [34] , rate, cardiac output and LV dP/dt in our anaesthetised systemic b-adrenoceptor vasodilator responses after L-MAX experimental preparation [23] [24] [25] . An initial rise in mean NNA were enhanced as a consequence of the elevation of aortic blood pressure (Table 1 ) was mostly likely due to arterial tone accompanying NOS inhibition. a -adrenoceptor-mediated vasoconstriction which is
In our study, systemic NOS inhibition augmented rises 1 known to occur at low dobutamine doses [26] , whereas the in LV dP/dt elicited by intravenous dobutamine infu-MAX subsequent reduction in aortic blood pressure below sion. At first glance, this result would appear to imply that, baseline levels was consistent with a predominance of as with intracoronary co-infusion of a NOS inhibitor and b -adrenoceptor-mediated vasodilation at higher dobutamine in anaesthetised dogs [9] , an NO-mediated 2 dobutamine doses [16, 26] . mechanism had attenuated increases in LV isovolumic Despite the similar rise in mean aortic pressure induced performance during infusion of dobutamine alone. Howby L-NNA and aortic occlusion, these interventions difever, our findings differed in a major respect from that of fered in a number of other haemodynamic respects. Thus, Keaney et al.
[9] because the demonstration of enhanced while NOS inhibition was accompanied by well-docu-LV dP/dt responses in their experimental preparation MAX mented reductions in cardiac output and heart rate was not evident in autonomically-intact animals, but [2,12,13], cardiac output increased and heart rate remained instead required abolition of autonomic reflexes with unchanged after partial aortic occlusion. On the other hand, bilateral vagotomy and hexamethonium-induced ganglionic LV dP/dt was unchanged after systemic L-NNA adblockade [35, 36] . More importantly, dobutamine-induced MAX ministration whereas, in accord with previous reports rises in LV dP/dt in our study were potentiated to a MAX [19, 27] , it rose after arterial occlusion. Increases in left similar extent as after NOS inhibition following elevation atrial pressure, which presumably represented the recruitof aortic blood pressure via arterial occlusion. Taken ment of a preload reserve mechanism in response to together, our L-NNA and aortic occlusion data therefore marked increase in LV afterload [28] , were more prominent imply that the potentiation of dobutamine-related LV after NOS inhibition than arterial occlusion. Finally, an isovolumic responses occurring after systemic NOS inhibiincrease in LV stroke work, which has previously been tion was predominantly related to the effect of a peripheral reported in anaesthetised dogs after elevation of aortic vascular action of NOS inhibition on the heart, rather than blood pressure with aortic constriction or angiotensin the inhibition of myocardial NO synthesis per se. infusion [14] , was less pronounced with NOS inhibition Our conclusion that increased aortic blood pressure, than with arterial occlusion. Taken together, these findings whether produced by NOS inhibition or mechanical means, suggest that the cardiac manifestations of systemic NOS played a major role in the potentiation of LV isovolumic inhibition occur via multifactorial actions and are not responses to dobutamine is consistent with previous studies solely a consequence of rises in aortic blood pressure. This in conscious and in anaesthetised dogs which noted that is consistent with the presence of NOS in a range of cell rises in LV dP/dt elicited by infusion of isoproterenol MAX types including endothelial and endocardial cells, neurons could be further enhanced by a superimposed increase in and myocytes, and the implication of NO not only in the aortic blood pressure produced by either constriction of the modulation of vascular tone, but also processes such as descending thoracic aorta or administration of angiotensin central and peripheral sympathetic neurotransmission and [14, 15] . The potential importance of changes in systemic myocardial relaxation [2] [3] [4] 29] .
blood pressure in the modulation of b-adrenergic inotropic While haemodynamic changes occurring with responses is also emphasised by a patient study which dobutamine infusion after L-NNA or aortic occlusion were noted that, following myocardial NOS inhibition, concomi- The precise nature of the mechanism(s) responsible for resulted in a decrease of myoplasmic cyclic GMP syn- [12] Kane DW, Tesauro T, Koizumi T, Gupta R, Newman JH. Exercisethesis, with a resultant increase in myofilament sensitivity induced pulmonary vasoconstriction during combined blockade of to calcium [36] , and removal of the inhibitory effect of nitric oxide synthase and beta adrenergic receptors. J Clin Invest
